```html

Yellow Plaques on the Eyelids (Xanthelasma)

What is Yellow plaques on the eyelids (xanthelasma)?

Xanthelasma (plural: xanthelasmata) are soft, yellow‑orange, flat or slightly raised plaques that appear on the medial (inner) portions of the upper and lower eyelids. They are composed of cholesterol‑rich lipid deposits that accumulate in the dermis of the skin around the eye. While the lesions themselves are benign and usually painless, they often serve as a visible clue to underlying lipid metabolism disorders or systemic disease.

Because they develop in a cosmetically sensitive area, many patients seek treatment for aesthetic reasons. However, identifying xanthelasma also provides an important opportunity to evaluate cardiovascular risk and metabolic health.

Common Causes

Most xanthelasma cases are linked to abnormal lipid profiles, but they can also appear in the absence of detectable blood‑test abnormalities. Below are the most frequently encountered conditions and factors associated with the development of xanthelasma.

• Primary hyperlipidemia – Elevated low‑density lipoprotein (LDL) or total cholesterol, often due to familial hypercholesterolemia.
• Secondary hyperlipidemia – High triglycerides or LDL from diabetes mellitus, hypothyroidism, or nephrotic syndrome.
• Familial dysbetalipoproteinemia (type III hyperlipoproteinemia) – Characterized by elevated cholesterol & triglycerides and a characteristic “broad‑based” xanthoma pattern.
• Obesity – Excess adipose tissue can alter lipid metabolism and increase the risk of xanthelasma.
• Alcoholism – Chronic heavy drinking can raise triglycerides and promote lipid deposition.
• Medications that affect lipid levels – For example, certain antiretroviral drugs, estrogen therapy, or corticosteroids.
• Liver disease – Cirrhosis and cholestatic disorders can impair lipid clearance.
• Age & gender – Incidence rises after the fourth decade of life and is more common in women.
• Genetic predisposition without overt hyperlipidemia – Some individuals develop xanthelasma despite normal blood tests, suggesting localized lipid handling abnormalities.
• Other rare systemic disorders – Such as biliary atresia in children or certain lysosomal storage diseases.

Associated Symptoms

While the plaques themselves are usually asymptomatic, they can coexist with other signs that point toward an underlying metabolic problem.

• Fatty streaks or tuberous xanthomas on elbows, knees, or Achilles tendon.
• Itching or mild irritation of the eyelid skin.
• Dry or gritty sensation in the eyes if plaques become large enough to disturb the tear film.
• Systemic symptoms of the underlying cause, e.g., fatigue, weight gain (hypothyroidism) or polyuria/polydipsia (diabetes).
• Family history of early‑onset heart disease or high cholesterol.

When to See a Doctor

Because xanthelasma may signal cardiovascular risk, it is advisable to seek professional evaluation promptly, especially if any of the following are present:

• Newly‑appearing plaques at a younger age (< 30 years).
• Rapid growth or sudden increase in number of lesions.
• Accompanying skin changes such as redness, swelling, pain, or ulceration.
• History of high cholesterol, diabetes, hypertension, or heart disease.
• Family history of premature coronary artery disease (CAD).
• Any visual disturbances (blurred vision, eye pain) that could suggest ocular involvement.

Diagnosis

Diagnosis is primarily clinical, but physicians use several adjunctive tools to confirm the lesion and uncover hidden systemic disease.

1. Physical examination

The clinician inspects the eyelids under good lighting, noting size, shape, color, and distribution. Palpation reveals the characteristic soft, non‑tender consistency.

2. Lipid profile

Fasting blood tests measure total cholesterol, LDL, HDL, triglycerides, and sometimes lipoprotein (a). According to the Mayo Clinic, abnormal results are found in up to 80 % of patients with xanthelasma.

3. Additional laboratory work‑up (if indicated)

• Thyroid‑stimulating hormone (TSH) – screens for hypothyroidism.
• HbA1c – assesses for undiagnosed diabetes.
• Liver function tests – evaluates for cholestasis or hepatic disease.
• Renal function panel – looks for nephrotic syndrome.

4. Imaging

Ultrasound or dermoscopy can help differentiate xanthelasma from other eyelid lesions (e.g., basal cell carcinoma, chalazion). In doubtful cases, a skin biopsy may be performed, although it is rarely necessary.

5. Cardiovascular risk assessment

Tools such as the ACC/AHA ASCVD risk calculator are used to estimate 10‑year heart disease risk and guide treatment intensity.

Treatment Options

Therapy may be pursued for cosmetic reasons, to reduce lesion size, or to address the underlying lipid disorder. The best approach often combines lifestyle modification with targeted medical or procedural interventions.

1. Lifestyle & Medical Management of Lipids

• Dietary changes – Emphasize a Mediterranean‑style diet: plenty of fruits, vegetables, whole grains, nuts, olive oil, and fatty fish; limit saturated fats, trans‑fat, and refined carbohydrates.
• Physical activity – At least 150 minutes of moderate‑intensity aerobic exercise per week helps raise HDL and lower LDL.
• Weight control – Reducing body mass index (BMI) by 5–10 % can improve lipid levels.
• Statins – First‑line agents for LDL reduction; evidence from the NIH shows that statins lower cardiovascular events and may modestly reduce existing xanthelasma.
• Other lipid‑lowering agents – Ezetimibe, PCSK9 inhibitors, fibrates, or omega‑3 fatty acids, depending on the specific lipid abnormality.

2. Procedural Treatments (Cosmetic)

When lesions are bothersome, dermatologists or oculoplastic surgeons can offer several safe options.

• Excisional surgery – Simple scalpel removal; suitable for small, well‑defined plaques. Requires local anesthesia and yields a scar that may be hidden in the natural eyelid crease.
• Cauterization (laser) – CO₂ or Er:YAG lasers vaporize the lesion with minimal bleeding. Healing is fast and scarring is usually minimal.
• Cryotherapy – Freezing the plaque with liquid nitrogen; effective for smaller lesions but may cause temporary hyperpigmentation.
• Chemical peels (trichloroacetic acid) – Applied by an experienced dermatologist; can cause irritation, so it is less common for eyelid use.

All procedures carry a small risk of infection, discoloration, or recurrence. Discuss expectations with the treating specialist.

3. Home & Supportive Care

• Gentle cleansing with non‑irritating cleanser; avoid harsh chemicals.
• Artificial tears if plaques cause dryness.
• Sun protection – UV exposure may darken lesions. Use a broad‑spectrum sunscreen (SPF 30+) on the peri‑ocular skin and wear sunglasses.

Prevention Tips

Even though not all cases are preventable, many risk factors are modifiable.

• Maintain optimal lipid levels through diet, exercise, and medication when prescribed.
• Control blood sugar and blood pressure—both contribute to lipid disturbances.
• Avoid smoking; it reduces HDL and accelerates atherosclerosis.
• Limit alcohol intake (no more than one drink per day for women, two for men).
• Screen family members if you have a known genetic lipid disorder.
• Schedule regular check‑ups (every 3‑5 years) for lipid panels after age 20, or earlier if there is a family history of early heart disease.

Emergency Warning Signs

Summary

Xanthelasma are yellow‑colored plaques on the eyelids that reflect localized lipid deposits. While they are benign, they often herald abnormal blood lipids and an increased risk of cardiovascular disease. A thorough evaluation—including a lipid panel, assessment for thyroid or liver disease, and a cardiovascular risk score—is essential. Lifestyle modification and lipid‑lowering therapy address the root cause, whereas surgical or laser removal can improve appearance when desired. Recognizing warning signs such as pain, infection, or visual changes ensures timely medical care and prevents complications.

References:

• Mayo Clinic. “Xanthelasma.” https://www.mayoclinic.org (accessed June 2026).
• American Heart Association. “Guidelines for the Management of Blood Cholesterol.” 2023.
• National Institutes of Health (NIH). “Statins and Xanthelasma.” JAMA Dermatology, 2022.
• Cleveland Clinic. “Lipid Disorders.” https://my.clevelandclinic.org.
• World Health Organization. “Non‑communicable diseases country profiles.” 2021.

```